These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 37563671)

  • 121. Polycystic ovary syndrome and type 2 diabetes mellitus: A state-of-the-art review.
    Livadas S; Anagnostis P; Bosdou JK; Bantouna D; Paparodis R
    World J Diabetes; 2022 Jan; 13(1):5-26. PubMed ID: 35070056
    [TBL] [Abstract][Full Text] [Related]  

  • 122. Prolactin Level in Polycystic Ovary Syndrome (PCOS): An approach to the diagnosis and management.
    Davoudi Z; Araghi F; Vahedi M; Mokhtari N; Gheisari M
    Acta Biomed; 2021 Nov; 92(5):e2021291. PubMed ID: 34738596
    [TBL] [Abstract][Full Text] [Related]  

  • 123. PCOS and Depression: Common Links and Potential Targets.
    Kolhe JV; Chhipa AS; Butani S; Chavda V; Patel SS
    Reprod Sci; 2022 Nov; 29(11):3106-3123. PubMed ID: 34642910
    [TBL] [Abstract][Full Text] [Related]  

  • 124. Genetic Basis of Polycystic Ovary Syndrome (PCOS): Current Perspectives.
    Khan MJ; Ullah A; Basit S
    Appl Clin Genet; 2019; 12():249-260. PubMed ID: 31920361
    [TBL] [Abstract][Full Text] [Related]  

  • 125. Hyperandrogenic origins of polycystic ovary syndrome - implications for pathophysiology and therapy.
    Abbott DH; Dumesic DA; Levine JE
    Expert Rev Endocrinol Metab; 2019 Mar; 14(2):131-143. PubMed ID: 30767580
    [TBL] [Abstract][Full Text] [Related]  

  • 126. Predicting Splicing from Primary Sequence with Deep Learning.
    Jaganathan K; Kyriazopoulou Panagiotopoulou S; McRae JF; Darbandi SF; Knowles D; Li YI; Kosmicki JA; Arbelaez J; Cui W; Schwartz GB; Chow ED; Kanterakis E; Gao H; Kia A; Batzoglou S; Sanders SJ; Farh KK
    Cell; 2019 Jan; 176(3):535-548.e24. PubMed ID: 30661751
    [TBL] [Abstract][Full Text] [Related]  

  • 127. GnRH dysregulation in polycystic ovarian syndrome (PCOS) is a manifestation of an altered neurotransmitter profile.
    Chaudhari N; Dawalbhakta M; Nampoothiri L
    Reprod Biol Endocrinol; 2018 Apr; 16(1):37. PubMed ID: 29642911
    [TBL] [Abstract][Full Text] [Related]  

  • 128. Emerging insights into hypothalamic-pituitary-gonadal axis regulation and interaction with stress signalling.
    Acevedo-Rodriguez A; Kauffman AS; Cherrington BD; Borges CS; Roepke TA; Laconi M
    J Neuroendocrinol; 2018 Oct; 30(10):e12590. PubMed ID: 29524268
    [TBL] [Abstract][Full Text] [Related]  

  • 129. Effects of single genetic variants and polygenic obesity risk scores on disordered eating in adolescents - The HUNT study.
    Sardahaee FS; Holmen TL; Micali N; Kvaløy K
    Appetite; 2017 Nov; 118():8-16. PubMed ID: 28694222
    [TBL] [Abstract][Full Text] [Related]  

  • 130. The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited.
    Rosenfield RL; Ehrmann DA
    Endocr Rev; 2016 Oct; 37(5):467-520. PubMed ID: 27459230
    [TBL] [Abstract][Full Text] [Related]  

  • 131. Dopamine 2 Receptor Genes Are Associated with Raised Blood Glucose in Schizophrenia.
    Lawford BR; Barnes M; Morris CP; Noble EP; Nyst P; Heslop K; Young RM; Voisey J; Connor JP
    Can J Psychiatry; 2016 May; 61(5):291-7. PubMed ID: 27254804
    [TBL] [Abstract][Full Text] [Related]  

  • 132. Polymorphic variants in the dopamine receptor D2 in women with endometriosis-related infertility.
    Szczepańska M; Mostowska A; Wirstlein P; Skrzypczak J; Misztal M; Jagodziński PP
    Mol Med Rep; 2015 Aug; 12(2):3055-60. PubMed ID: 25955176
    [TBL] [Abstract][Full Text] [Related]  

  • 133. Polycystic ovary syndrome, insulin resistance, and obesity: navigating the pathophysiologic labyrinth.
    Rojas J; Chávez M; Olivar L; Rojas M; Morillo J; Mejías J; Calvo M; Bermúdez V
    Int J Reprod Med; 2014; 2014():719050. PubMed ID: 25763405
    [TBL] [Abstract][Full Text] [Related]  

  • 134. Sex-specific effects of naturally occurring variants in the dopamine receptor D2 locus on insulin secretion and type 2 diabetes susceptibility.
    Guigas B; de Leeuw van Weenen JE; van Leeuwen N; Simonis-Bik AM; van Haeften TW; Nijpels G; Houwing-Duistermaat JJ; Beekman M; Deelen J; Havekes LM; Penninx BW; Vogelzangs N; van 't Riet E; Dehghan A; Hofman A; Witteman JC; Uitterlinden AG; Grarup N; Jørgensen T; Witte DR; Lauritzen T; Hansen T; Pedersen O; Hottenga J; Romijn JA; Diamant M; Kramer MH; Heine RJ; Willemsen G; Dekker JM; Eekhoff EM; Pijl H; de Geus EJ; Slagboom PE; 't Hart LM
    Diabet Med; 2014 Aug; 31(8):1001-8. PubMed ID: 24724616
    [TBL] [Abstract][Full Text] [Related]  

  • 135. Dopamine regulation of gonadotropin-releasing hormone neuron excitability in male and female mice.
    Liu X; Herbison AE
    Endocrinology; 2013 Jan; 154(1):340-50. PubMed ID: 23239814
    [TBL] [Abstract][Full Text] [Related]  

  • 136. MirSNP, a database of polymorphisms altering miRNA target sites, identifies miRNA-related SNPs in GWAS SNPs and eQTLs.
    Liu C; Zhang F; Li T; Lu M; Wang L; Yue W; Zhang D
    BMC Genomics; 2012 Nov; 13():661. PubMed ID: 23173617
    [TBL] [Abstract][Full Text] [Related]  

  • 137. Annotation of functional variation in personal genomes using RegulomeDB.
    Boyle AP; Hong EL; Hariharan M; Cheng Y; Schaub MA; Kasowski M; Karczewski KJ; Park J; Hitz BC; Weng S; Cherry JM; Snyder M
    Genome Res; 2012 Sep; 22(9):1790-7. PubMed ID: 22955989
    [TBL] [Abstract][Full Text] [Related]  

  • 138. PSEUDOMARKER: a powerful program for joint linkage and/or linkage disequilibrium analysis on mixtures of singletons and related individuals.
    Hiekkalinna T; Schäffer AA; Lambert B; Norrgrann P; Göring HH; Terwilliger JD
    Hum Hered; 2011; 71(4):256-66. PubMed ID: 21811076
    [TBL] [Abstract][Full Text] [Related]  

  • 139. Evidences for the existence of a low dopaminergic tone in polycystic ovarian syndrome: implications for OHSS development and treatment.
    Gómez R; Ferrero H; Delgado-Rosas F; Gaytan M; Morales C; Zimmermann RC; Simón C; Gaytan F; Pellicer A
    J Clin Endocrinol Metab; 2011 Aug; 96(8):2484-92. PubMed ID: 21646367
    [TBL] [Abstract][Full Text] [Related]  

  • 140. Pharmacological modulation of dopamine receptor D2-mediated transmission alters the metabolic phenotype of diet induced obese and diet resistant C57Bl6 mice.
    de Leeuw van Weenen JE; Parlevliet ET; Schröder-van der Elst JP; van den Berg SA; Willems van Dijk K; Romijn JA; Pijl H
    Exp Diabetes Res; 2011; 2011():928523. PubMed ID: 21603181
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.